We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DYAI:NASDAQDyadic International, Inc. Analysis

Data as of 2026-09-08 - not real-time

$0.52

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind Dyadic International, Inc. is neutral at $0.5201, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 54.0%. With RSI at 25.4 the momentum picture is oversold, alongside a bearish MACD signal. Price has been bracketed by support at $0.4800 and resistance at $1.10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 957.5% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 80.8%, a beta of 0.89 and a maximum drawdown of 66.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Dyadic to host earnings call on August 12 at 5:00 pm ETJUPITER, Fla.JUPITER, Fla., Aug. 13, 2026 GLOBE NEWSWIRE -- Dyadic International, Inc. NASDAQ: DYAI the “Company” , d/b/a Dyadic...Despite a 52% revenue increase and significant productivity gains, Dyadic International Inc DYAI faces a going concern...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 25.4 signals oversold conditions
  • Trading below the 200-day average of 0.86
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 25.4 signals oversold conditions
  • Trading below the 200-day average of 0.86
  • Analyst targets imply +957.5% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -200.5%
  • Analyst targets imply +957.5% versus the current price
  • Revenue contracting at -0.6%

Key Metrics & Analysis

Financial Health

Revenue Growth-0.60%
Profit Margin-200.46%
P/E Ratio-1.6
ROA-62.99%
P/B Ratio-7.9
Op. Cash Flow$-7403841
Free Cash Flow$-4809161
Industry P/E29.9

Technical Analysis

TrendNeutral
RSI25.4
Support$0.48
Resistance$1.10
MA 20$0.68
MA 50$0.93
MA 200$0.86
MACDBearish
VolumeStable
Fear & Greed Index93.36

Valuation

Target Price$5.50
Upside/Downside957.49%
GradeFair
TypeBlend

Risk Assessment

Beta0.89
Volatility80.76%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.